Datasets:
CDR3 string | peptide string | HLA string | HLA_sequence string | label int64 |
|---|---|---|---|---|
CSARTEGAEAFF | CVNGSCFTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSYWTGSSAETQYF | CVNGSCFTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSRAGTGYNEQFF | KTFPPTEPK | A*11:01 | TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE | 1 |
CASSPSVYFEVSGANVLTF | KTFPPTEPK | A*11:01 | TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE | 1 |
CASSEVGVFEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSLGVNTEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSFRDLSSYNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSPALGDQETQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASRPGQHTGELFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSVEEGLQTGELFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSAETGNTEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSEVADYNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSLEGDTEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSEFQGDNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSDGSFNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSVGDLLTGELFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CATSDLEGWTQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CANPPGSSYNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSATRLAGGPTDTQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSVALGNQETQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSQAGSSYEQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSAEQGNTEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSPGTGGNEQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSLDLPGPEGETQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSAEDGNSPLHF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CAWSPAGLAMYEQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSEAGGPGYEQYF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSVRDISTNEKLFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CSAESGNTEAFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSSPSGVYNEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSVDLKAGEEGEQFF | DATYQRTRALVR | A*68:01 | TVGFFDAQRGPPWEQPEDQDVGHIGIKDWAAAKE | 1 |
CASSLRGGQSYEQYF | MLYQHLLPL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSQWDNQPQHF | WMRLLPLL | B*08:01 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CAISEGAPNTEAFF | FGDHPGHSY | A*01:01 | TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE | 1 |
CASSGGAVAPSEQFF | GLCTLVAML | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSHTTGDDYGYTF | KSKRTPMGF | B*57:01 | TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE | 1 |
CASSLTSTRQPQHF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSPPQFTEAFF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSSSLVVEQYF | RAQAPPPSW | B*57:01 | TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE | 1 |
CASSFPGQGNTQYF | RAQAPPPSW | B*57:01 | TLGFFDAPRGPPWEQPEDQYEGHIGINDWAAAQE | 1 |
CASSVASGQLYGYTF | RLGPVQNEV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASRVGQNYNSPLHF | RLGPVQNEV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSQDAPGQGSDEQFF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSPGTGGPFSEQYF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSLVTGNQPQHF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSEGDRGLANEKLFF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CASSLGRAGYGETQYF | HYPYRLWHY | A*03:01 | TLGFFDAQRGPPWEQPEDQDVGHIGINDWAAAKE | 1 |
CAISESSSGNNEQFF | ATDALMTGF | A*01:01 | TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE | 1 |
CASSQAPPGQGVDIQYF | GPRLGVRAT | B*07:02 | TLGFFDAPRGPPWEQPEDQDEGHLGINDWAAAQE | 1 |
CATSGDTQYF | KLVAMGINAV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSLNWGSGYNEQFF | KLVAMGINAV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSLEGGDEQFF | KLVAMGINAV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSVETTGELFF | KLVAMGINAV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASIGWGELFF | KLVAMGINAV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSEGLWQVGDEQYF | HMTEVVRHC | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CAISELVTGDSPLHF | HMTEVVRHC | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSIQQGADTQYF | HMTEVVRHC | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSLGEGRVDGYTF | GADGVGKSAL | C*08:02 | TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE | 1 |
CASSDPGTEAFF | GADGVGKSAL | C*08:02 | TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE | 1 |
CASSFGQSSTYGYTF | GADGVGKSAL | C*08:02 | TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE | 1 |
CASSLGRASNQPQHF | GADGVGKSAL | C*08:02 | TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE | 1 |
CASSLGQTNYGYTF | GADGVGKSAL | C*08:02 | TICFFDAPRGPPWEQPEDQDVGHLGINDWAAAQE | 1 |
CASSSQGGYGYTF | KVDPIGHVY | A*01:01 | TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE | 1 |
CASSFDRGYGYTF | KVDPIGHVY | A*01:01 | TLGFFDAQKGPPWEQPEDQDAGHIGINDWAAAKE | 1 |
CASSLSGGLLRTGELFF | FVVPYMIYLL | C*03:03 | TIGFFDAPRGPPWEQPEDQDVRHIGINDWAAAQE | 1 |
CASSGRVTGGFYNEQFF | VQIISCQY | A*30:02 | TLGFFDAQRRPPWEQPEDQDEGHIGINDWAAAQE | 1 |
CASSFGGAYEQYF | VQIISCQY | B*15:01 | TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE | 1 |
CASSLVSPSEQFF | YLSNIIPAL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSLFTGTNEQFF | QLCDVMFYL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSLDQGAQDNEQFF | YLYDRLLRV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CATSFAPGQGEHGYTF | LYPEFIASI | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASSTSTGQGWHYGYTF | MLIGIPVYV | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASRPSRGTNYGYTF | KLYGLDWAEL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSERGMVEAFF | KLYGLDWAEL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSPRNLGPSGSYEQYF | KLYGLDWAEL | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSQNYEQYF | ALDPHSGHFV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSYSWGAGYEQYF | ALDPHSGHFV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASTPTGAYEQYF | ALDPHSGHFV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CSAGTGELFF | ALDPHSGHFV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CSARVGDTGELFF | ALSPVIPHI | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSYDSTTGELFF | ALSPVIPHI | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASTPGGYEQYF | KLFEFLVYGV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSQGYEQYF | KLFEFLVYGV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSPAALSGAYEQYF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSRRSSGELFF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSRDSALWISTDTQYF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASRLGTGPEAFF | EAAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSFGLGTEAFF | EAAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSPPGLSGNIQYF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSPGTLADTQYF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASAWGGMTNEQYF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSETGGTEAFF | EAAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSDQGLGTEAFF | EAAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASRSLGQGAEKLFF | ELAGIGILTV | A*02:01 | TVGFFDAQRGPPWEQPEDQHVGHVGIKDWAAAKE | 1 |
CASSRGTLHYGYTF | FYGKTILWF | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASSLGQGCSNQPQHF | FYGKTILWF | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASSLGAAPQETQYF | FYGKTILWF | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASSTRVVAGNNEQFF | FYGKTILWF | A*24:02 | TVGFFDAQRGPPWEQPEDQDEGHLGIKDWAAAKE | 1 |
CASSPGVGTEAFF | EFTVSGNIL | B*40:01 | TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE | 1 |
CASSPGASYEQYF | ESITGSLGPLL | B*40:01 | TLGFFDAPRGPPWEQPEDQYEGHLGINDWAAAQE | 1 |
Temporal OOD Dataset for TCR-pMHC Binding Prediction
Dataset Description
The Temporal OOD (Out-of-Distribution) Dataset evaluates TCR-pMHC binding prediction models under temporal shift. This dataset contains SARS-CoV-2 T cell receptor sequences collected during the COVID-19 pandemic, providing a natural test of model generalization to time-lagged data.
Key Features
- Temporal Shift Testing: Data collected after training set construction
- COVID-19 Focus: SARS-CoV-2 T cell repertoire from pandemic
- Complete PMT Data: All samples include CDR3, peptide, and HLA
- Multi-Laboratory: Compiled from multiple research laboratories
- Experimentally Validated: All TCR-pMHC interactions experimentally annotated
Dataset Details
Construction Method
This dataset follows the out-of-date testing protocol introduced in FusionPMT, using the external SARS-CoV-2 repertoire from VDJdb's recent update. The sequences were:
- Collected during COVID-19 pandemic by multiple laboratories
- Experimentally annotated for peptide and HLA specificities
- Filtered using standard quality control rules
- Deduplicated to remove redundant entries
- Validated for completeness
Statistics
- Total Samples: 13979
- Positive Samples: 1272 (9.1%)
- Negative Samples: 12707 (90.9%)
- Unique TCR Sequences: N/A
- Unique Peptide Epitopes: 239
- Unique HLA Alleles: 48
Data Format
CSV file with the following columns:
| Column | Type | Description | Required |
|---|---|---|---|
| CDR3 | string | TCR CDR3beta amino acid sequence | Yes |
| peptide | string | Peptide amino acid sequence | Yes |
| HLA | string | HLA allele (e.g., A*02:01) | Yes |
| label | int | Binding label (1=binder, 0=non-binder) | Yes |
| HLA_sequence | string | HLA pseudo-sequence | Optional |
Peptide Length Distribution
- 7aa: 54 samples (0.4%)\n- 8aa: 1016 samples (7.3%)\n- 9aa: 9287 samples (66.4%)\n- 10aa: 2662 samples (19.0%)\n- 11aa: 729 samples (5.2%)\n- 12aa: 137 samples (1.0%)\n- 13aa: 42 samples (0.3%)\n- 20aa: 52 samples (0.4%)
Label Distribution
- Binders (label=1): 1272 samples
- Non-binders (label=0): 12707 samples
- Imbalance Ratio: ~1:10.0 (positive:negative)
Usage
Load with Hugging Face Datasets
from datasets import load_dataset
dataset = load_dataset("YYJMAY/temporal-ood")
df = dataset['train'].to_pandas()
Load with Pandas
import pandas as pd
from huggingface_hub import hf_hub_download
file_path = hf_hub_download(
repo_id="YYJMAY/temporal-ood",
filename="temporal_ood.csv",
repo_type="dataset"
)
df = pd.read_csv(file_path)
Use with SPRINT Framework
from sprint.core.dataset_manager import DatasetManager
manager = DatasetManager()
dataset_config = {
'hf_repo': 'YYJMAY/temporal-ood',
'files': ['temporal_ood.csv'],
'test': 'temporal_ood.csv'
}
files = manager.get_dataset('temporal_ood', dataset_config)
test_file = files['test']
Scientific Context
Temporal Shift Challenge
This dataset addresses a critical challenge in machine learning for immunology: temporal generalization. Models trained on historical data must generalize to new sequences collected at later time points. The COVID-19 pandemic provides a unique natural experiment for this evaluation.
Why Temporal OOD Matters
- Real-world Deployment: Clinical applications require models that work on future data
- Emerging Pathogens: New disease outbreaks generate novel epitopes
- Distribution Drift: Immune repertoires evolve over time
- Model Robustness: Tests whether models learn fundamental biology vs. dataset artifacts
Biological Significance
- SARS-CoV-2 Epitopes: Includes key viral peptides recognized by T cells
- Pandemic Diversity: Represents diverse patient populations and disease stages
- Laboratory Consensus: Multi-laboratory validation increases reliability
- Clinical Relevance: Direct connection to COVID-19 immune response research
Task Compatibility
- PMT Task: Yes (all samples have CDR3)
- PM Task: Yes (peptide-HLA pairs available)
All 13979 entries are suitable for TCR-peptide-MHC (PMT) binding prediction.
Quality Control
Filtering Rules Applied
- Removed entries with missing CDR3, peptide, or HLA
- Removed duplicate (CDR3, peptide, HLA, label) combinations
- Validated label values (0 or 1 only)
- Checked for empty strings in critical columns
- Verified HLA sequence availability
Data Integrity
- No Missing Values: All required columns complete
- No Duplicates: 659 duplicates removed during preprocessing
- Valid Labels: All labels are binary (0 or 1)
- Standardized Format: Consistent with other SPRINT datasets
Comparison with Training Data
This dataset intentionally differs from training data in temporal dimension:
| Aspect | Training Data | Temporal OOD |
|---|---|---|
| Collection Period | Pre-pandemic | During COVID-19 pandemic |
| Epitope Source | Various pathogens | SARS-CoV-2 dominant |
| Data Vintage | Historical | Recent/contemporary |
| Distribution | Established | Time-shifted |
Benchmark Results
This dataset is used to evaluate multiple TCR-pMHC binding prediction methods in the SPRINT benchmark suite. Expected performance characteristics:
- Difficulty: Moderate to challenging due to temporal shift
- Baseline: Random classifier ~9.1% (positive class frequency)
- Evaluation Metrics: AUC, AUPR, F1, Precision, Recall
Citation
If you use this dataset, please cite:
@dataset{temporal_ood_2024,
title={Temporal OOD Dataset for TCR-pMHC Binding Prediction},
author={SPRINT Framework Contributors},
year={2024},
note={SARS-CoV-2 T cell repertoire data from VDJdb},
url={https://huggingface.co/datasets/YYJMAY/temporal-ood}
}
And the original VDJdb paper:
@article{goncharov2022vdjdb,
title={VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium},
author={Goncharov, Mikhail and others},
journal={Nucleic Acids Research},
year={2022}
}
Related Datasets
- Allelic OOD: Tests generalization to rare HLA alleles
- Modality OOD: Tests cross-modality generalization (BA ↔ EL)
- FusionPMT Training: Original training data
Limitations
- COVID-19 Bias: Heavy emphasis on SARS-CoV-2 epitopes
- Temporal Specificity: Limited to pandemic time period
- Imbalanced Labels: Negative samples dominate (~87%)
- HLA Coverage: 48 alleles, may not cover all population diversity
License
MIT License - Free for academic and commercial use
Contact
For questions, issues, or contributions:
- Dataset repository: YYJMAY/temporal-ood
- SPRINT framework: https://github.com/Computational-Machine-Intelligence/SPRINT
Acknowledgments
- VDJdb team for SARS-CoV-2 repertoire data
- Multiple laboratories contributing T cell sequences during COVID-19 pandemic
- FusionPMT authors for temporal OOD protocol design
- Downloads last month
- 8